Is Sandostatin a chemotherapy drug?

Long-acting octreotide, commonly known as Sandostatin LAR, refers to the microspheres for injection containing octreotide acetate. It is not a chemotherapy drug but belongs to a class of hormonal medications. Detailed analysis is as follows:

The main active ingredient in octreotide acetate microspheres for injection is octreotide acetate. It is primarily used to treat acromegaly, as well as carcinoid tumors with carcinoid syndrome features, vasoactive intestinal peptide tumors (VIPomas), glucagonomas, and insulinomas. This medication is not suitable for patients who have not responded to surgery, radiotherapy, or chemotherapy. It should also not be used in patients who are in a potential response phase before radiotherapy has fully taken effect.

It is recommended to follow a physician's guidance for proper use of this medication. The drug must be administered via deep intramuscular injection in the buttocks and should not be given intravenously.